The Uro-GHD features a 1280x720 pixel sensor, a first in portable, single-use endoscopy. LOS ALTOS, CA / ACCESSWIRE / April 7, 2023 / UroViu Corp (www.uroviu.com) has launched the new Uro-GHD, a ...
Adding Bladder EpiCheck to cystoscopy for non-muscle invasive bladder cancer (NMIBC) surveillance and, if positive, performing biopsy under photodynamic diagnosis (PDD), significantly improved ...
Cystoscopy without the aid of urinary markers is the most cost-effective strategy for detecting recurrence of non-invasive bladder cancer, according to researchers. In a study that examined five ...
LOS ALTOS, Calif.--(BUSINESS WIRE)--UroViu Corporation announced today that it has received CE certification for its cystoscope and hysteroscope product portfolio. This includes the reusable UV5000w ...
In a trial, Xpert® Bladder Cancer Monitor, a non-invasive urinary biomarker test, appeared suitable for guiding cystoscopy during monitoring of patients with NMIBC. Alternating between cystoscopy and ...
UroViu Corporation, a company develops a suite of diagnostic and therapeutic endoscopic products, has announced that its Uro-V single-use diagnostic cystoscopic system has received 510(k) clearance ...
NEW ORLEANS -- Using a tool to classify patients' infection risk and providing education and systems-level changes in the urology department safely reduced prophylactic antibiotic use around ...
Bladder biopsy of normal-looking mucosa, as determined by cystoscopy, might not add clinical value in patients with positive voided-urine cytology after treatment of non-muscle-invasive bladder cancer ...
ORANGEBURG, N.Y., May 13, 2011 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI) announced today the introduction by Stryker Corporation ("Stryker") of the new line of EndoSheath Cystoscopy ...
Cystoscopy remains an essential diagnostic procedure in urology, yet it is frequently associated with discomfort and pain that may compromise patient compliance and overall procedural experience.
SHANGHAI, Feb. 21, 2023 /PRNewswire/ -- Asieris Pharmaceuticals (688176), a global biopharma company specializing in discovering, developing and commercializing innovative drugs for the treatment of ...
A single-dose of URO-902 may prove to be an effective treatment strategy for women with overactive bladder and urge urinary incontinence, according to findings from the final analysis of a phase IIa ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results